Pfizer
Q3 2022 Earnings Call
Nov 01, 2022, 10:00 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Good day, everyone, and welcome to Pfizer's third quarter 2022 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, senior vice president and chief investor relations officer.
Please go ahead, sir.
Chris Stevo -- Senior Vice President and Chief Investor Relations Officer
Good morning. Welcome to Pfizer's third-quarter earnings call. We anticipate that this call will last 60 minutes. I'm joined today by Dr.
Albert Bourla, our chairman and CEO; Dave Denton, our CFO; and Dr. Mikael Dolsten, president of worldwide research and development and medical. Joining for the Q&A session, we will also have Angela Hwang, chief commercial officer and president, global biopharmaceuticals business; Aamir Malik, our chief business innovation officer; Dr. William Pao, our chief development officer; and Doug Lankler, our general counsel.
Before we begin the call, I'm also happy to announce that we will host an Analyst Day in New York City on the afternoon of December 12. Members of our executive team and other leaders of Pfizer will share information on our rich slate of potential near-term product launches and the R&D readouts which will drive the next wave of product launches after that, both of which will support our 2030 revenues and beyond. In-person attendance will be by invitation, but we will also be webcasting the event. While we're not going to talk more about the agenda today, we look forward to providing more details as we get closer to December 12.
Materials for this call and other earnings-related materials are on the Investor Relations section of pfizer.com. Please see our forward-looking statements disclaimer on Slide 4. And additional information regarding these statements and our non-GAAP financial measures is available in our earnings release and in our SEC forms 10-K and 10-Q under Risk Factors and Forward-looking Information and Factors That May Affect Future Results. Forward-looking statements on the call are subject to substantial risks and uncertainties, speak only as of the call's original date, and we undertake no obligation to update or revise any of these statements.
With that, I will turn the call over to Albert.
Albert Bourla -- Chairman and Chief Executive Officer